CVA Family Office’s Nova NVMI Stock Holding History

CVA Family Office’s Portfolio NVMI Stock Details NVMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$1.28K	–	1344
2025 Q3	$1.28K	Buy	+4	New	+$1.1K	﹤0.01%	1085

Other funds holding NVMI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CVA Family Office's NVMI Position: Q4 2025 in Review

CVA Family Office sold out of Nova (NVMI) in Q4 2025, closing a stake of 4 shares — an estimated $1.28K sold.

CVA Family Office first reported a position in NVMI in Q3 2025 and held it in 1 quarter. The position peaked at $1.28K in Q3 2025. 291 funds tracked by Wall St. Rank hold NVMI as of Q4 2025.

CVA Family Office reported no remaining Nova position as of Q4 2025 after selling out during the quarter.
CVA Family Office sold 4 Nova shares in Q4 2025, an estimated $1.28K.
CVA Family Office first reported a position in Nova in Q3 2025 and held it in 1 quarter.
CVA Family Office's Nova position peaked at $1.28K in Q3 2025.
291 funds tracked by Wall St. Rank held Nova as of Q4 2025.

Based on CVA Family Office's 13F filing for Q4 2025, filed 12 Jan 2026.